Overview

A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes

Status:
Completed
Trial end date:
2020-12-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the user experience of an integrated insulin management system (IIM) in participants with type 1 or type 2 diabetes. The IIM system is comprised of an insulin injection pen with a data transmission module and blood glucose meter which are connected to a mobile phone application. The application will be used to record and track diabetes-data related information.
Phase:
N/A
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Glargine
Insulin Lispro